CompuMed (OTCMKTS:CMPD) Announces Quarterly Earnings Results

CompuMed (OTCMKTS:CMPDGet Free Report) released its earnings results on Friday. The company reported $0.02 EPS for the quarter, Zacks reports. CompuMed had a negative net margin of 0.85% and a negative return on equity of 1.90%.

CompuMed Price Performance

OTCMKTS CMPD opened at $4.36 on Friday. CompuMed has a 12 month low of $1.95 and a 12 month high of $6.80. The firm has a market capitalization of $5.80 million, a PE ratio of -87.18 and a beta of -0.30. The company’s 50 day simple moving average is $4.00 and its 200 day simple moving average is $3.84. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.28 and a quick ratio of 2.26.

CompuMed Company Profile

(Get Free Report)

CompuMed, Inc, an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. It offers telecardiology and teleradiology services that provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities worldwide. The company also provides enterprise telemedicine solutions; a suite of telecardiology services and diagnostic exam interpretations for pediatric and adult patients, including electrocardiogram (ECG) devices, echocardiogram, ECG, vascular, holter, nuclear, and video consults; and reading, transcription, reporting, storage, and video consultations in the areas of Vscan, X-ray, ultrasound, mammography, computed tomography, magnetic resonance imaging, and radiologist video consults.

Read More

Earnings History for CompuMed (OTCMKTS:CMPD)

Receive News & Ratings for CompuMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuMed and related companies with MarketBeat.com's FREE daily email newsletter.